In vivo and in vitro experiments showed that IBI188 could bind to CD47 antigen on the surface of tumor cells and block CD47-SIRPα signal pathway, inhibit the "don't eat me" signal transmitted by CD47, so as to enable macrophages to recognize tumor cells and enable the anti-tumor effect. Here, CD47 is linked to neoplasm.